• Bradford Health Services Acquires Parkdale Center 

    Bradford Health Services has entered into an agreement to acquire Parkdale Center, a leading addiction treatment provider in Chesterton, Indiana.  Parkdale Center is widely renowned for its specialized Professionals Program serving healthcare providers, attorneys, executives, aviation professionals, first responders and other licensed... Read More »
  • RevSpring Acquires TrustCommerce 

    On February 20, RevSpring reported that it acquired TrustCommerce. The seller was Waud Capital Partners, who initially purchased the company in 2017.  FT Partners served as the exclusive strategic and financial advisor to TrustCommerce. Financial terms of the deal were not disclosed.  TrustCommerce is a leading financial technology... Read More »
  • Istios Health Expands into the Nephrology Field  

    On February 19, Istios Health reported that it was expanding its services into the nephrology field with the acquisition of three practices: Central Mass Nephrology, Teredesai McCann & Associates and Coordinated Kidney Care Group. Terms were not disclosed.   Central Mass Nephrology is a nephrology practice based out of nine clinic locations... Read More »
  • Swiss Rockets AG Acquires Complete Genomics 

    Swiss Rockets AG, based in Basel, Switzerland, announced on February 23 that it entered into a definitive agreement to acquire Complete Genomics, Inc.   Complete Genomics is a leader in whole human genomic sequencing, which is used by research centers to conduct medical research that, in the future, is expected to be used to improve... Read More »
  • Specialty1 Partners Announces Second Acquisition of 2025 

    Triumphant Transition Partners announced that it acted as an advisor to Dr. Francisco Perez as he joined Specialty1 Partners.  The practice of Dr. Francisco Perez is based in Edinburg, Texas. Dr. Perez, an oral and maxillofacial surgeon, is the only physician on staff.  Specialty1 Partners, backed by private equity firm VSS Capital Partners,... Read More »
ArchiMed-Backed NAMSA Acquires CRI

ArchiMed-Backed NAMSA Acquires CRI

NAMSA, a portfolio company of ArchiMed since September 2020, announced on July 18 its acquisition of Germany-based CRI. The addition of CRI to NAMSA is a significant move for NAMSA in Germany that enhances and expands its CRO offerings throughout Europe and across all markets. The price and terms of the transaction are undisclosed. CRI, The Clinical Research Institute, is a German-based full-service contract research organization (CRO) for phase III and IV clinical trials. NAMSA is a global medical device research company providing a range of services to improve efficacy, non-clinical and clinical safety of medical devices, IVDs and combination products. According to data captured in the... Read More »
Atlas Clinical Research Acquires Suburban Research Associates

Atlas Clinical Research Acquires Suburban Research Associates

Atlas Clinical Research announced the addition of Suburban Research Associates to its site network, marking the second clinical research site partnership for the platform. Atlas previously formed a strategic partnership with Rochester Clinical Research in April 2023. Specializing in psychiatric research, Suburban will seek to expand its research impact and leverage Atlas’ site connectivity to better serve trial patients. According to data captured in the LevinPro HC database, this transaction represents the 14th clinical trials acquisition of 2023. Founded in 1999 by Dr. Shivkumar Hatti, Suburban Research Associates is a clinical research site conducting psychiatric research from its... Read More »
Sendero Capital & Angelo Gordon Joint Venture Acquires New Haven MSA MOB

Sendero Capital & Angelo Gordon Joint Venture Acquires New Haven MSA MOB

JLL Capital Markets announced on July 12 that it advised on the acquisition of a 53,120-square-foot medical office building (MOB) in Hamden, Connecticut. According to data captured in the LevinPro HC database, this represents the 120th MOB transaction of 2023 JLL represented Sendero Capital and Angelo Gordon, who have formed a programmatic joint venture (also arranged by JLL) for up to $300 million in investments in outpatient healthcare real estate over the next two years, in the acquisition. The purchase of the Hamden MOB is the first acquisition as part of the joint venture, which will focus on value-add and core plus outpatient medical office and surgery center assets throughout the... Read More »
Versiti Acquires Fishers, Indiana-based Quantigen

Versiti Acquires Fishers, Indiana-based Quantigen

Versiti has announced the acquisition of Quantigen, a specialty lab based in Fishers, Indiana. The acquisition expands Versiti’s portfolio across the drug and medical device development pathway and adds complementary expertise supporting clinical trials in infectious disease, women’s health and gastrointestinal and reproductive health. Financial terms of the deal were not disclosed. Based in Fishers, Indiana, Quantigen is a contract research organization (CRO) and a patient diagnostic laboratory whose services are focused on supporting the development of novel diagnostic tests and medical devices. Versiti is a world-class blood health organization with locations across the... Read More »
RealTime Software Solutions Acquires Devana Solutions

RealTime Software Solutions Acquires Devana Solutions

RealTime Software Solutions, LLC, backed by Philadelphia-based private equity firm LLR Partners, has announced its acquisition of Devana Solutions, LLC for an undisclosed price. This strategic move delivers the most comprehensive and advanced end-to-end site platform available to the market. Devana Solutions’ cloud platform provides clinical trial data analytics for central research operations (CRO) professionals. The platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. RealTime Software Solutions provides software products for clinical trial research sites, site networks,... Read More »
Vitalis Acquires MOB in Tulsa, Oklahoma

Vitalis Acquires MOB in Tulsa, Oklahoma

Vitalis has acquired a 45,556-square-foot medical office building (MOB) in Tulsa, Oklahoma. The MOB is fully leased by three tenants, Oklahoma Heart Institute, Hillcrest HealthCare System and Lifestance Health. Oklahoma Heart Institute and Hillcrest HealthCare comprise 87% of the MOB. Services provided at the outpatient facility include a cardiac catheterization laboratory, imaging, electrophysiology and interventional cardiology. Vitalis is a vertically integrated real estate investment company focused on healthcare real estate investment sales, acquisitions and leasing across the United States. The MOB is strategically located less than a mile from Hillcrest Hospital South. Financial... Read More »